(Circulation. 2004;110:II-139 II-146.)
© 2004 American Heart Association, Inc.
Surgery for Congenital Heart Disease |
From the Department of Cardiothoracic Surgery (K.M., A.M., S.T.), Graduate School of Medicine, University of Tokyo, Japan; Japanese Research Institute of Pulmonary Vasculature (S.Y.), Miyagi, Japan; Fukuoka City Childrens Hospital (H.K.), Fukuoka, Japan; and Faculty of Medicine (T.A.), Kitazato University, Kanagawa, Japan.
Correspondence to Katsuhide Maeda, MD, Department of Cardiothoracic Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. E-mail maedak-tky{at}umin.ac.jp
| Abstract |
|---|
|
|
|---|
25 µm to 250 µm, in HLHS with restrictive ASD are hypoplastic, but that the alveoli are not, to elucidate the mechanism underlying the poor outcome of these patients. Methods and Results Fourteen HLHS patients between 1 day and 40 days of age were studied. In 8 cases, the ASD was restrictive [R(+) group], and in the other 6 cases it was not [R() group]. Specimens from 12 autopsies of cases with no congenital heart or pulmonary disease were examined as a control group (C group). As a novel histological parameter, we assessed the size of SPA in relation to the size of accompanying bronchioles to identify SPA underdevelopment. To evaluate the development of alveoli and interstitial tissue, radial alveolar counts (RAC), which reflect alveolar maturity and complexity, were also performed. Statistical comparisons between groups were made by analysis of covariance with age as a covariant factor. When the radius of the accompanying bronchiole was 100 µm, the radius of the SPA was 34.0±10.8 µm in the R(+) group, and significantly lower than the 46.6±8.5 µm in R() group (P=0.0022) and 70.5±8.4 µm in the C group (P<0.0001). The RAC was in 3.5±0.9 in the R(+) group, 3.4±0.6 in the R() group, and 3.7±0.9 in the C group (no significant differences between groups).
Conclusion The SPA in HLHS with restrictive ASD were underdeveloped compared with the SPA in HLHS with nonrestrictive ASD and the controls, but their alveoli were not hypoplastic. Based on these results, it is speculated that SPA hypoplasia may be responsible for the poor outcome of HLHS with restrictive ASD.
Key Words: hypoplastic left heart syndrome restrictive atrial septal defect lung pathology hypoplastic pulmonary artery
| Introduction |
|---|
|
|
|---|
Based on the aforementioned, to identify the mechanism, we collected lung specimens taken from HLHS cases with and without restrictive ASD and investigated various histological characteristics to determine the cause of the poor outcome of patients with restrictive ASD. To complement the various morphological analyses of the lungs in HLHS in previous studies, we used a novel technique described in our study in total anomalous pulmonary venous connection (TAPVC)8 to investigate the intrapulmonary arterial system. More specifically, we were interested in identifying underdevelopment of small pulmonary arteries (SPA), which are pulmonary arteries with muscular coats observed in biopsy specimens; their radii ranges from 25 µm to 250 µm. Although various types of pulmonary vascular lesions have been reported in HLHS with restrictive ASD, few have reported hypoplasia or underdevelopment of pulmonary arteries. One reason for this is that there had been no clear definition of SPA hypoplasia. We therefore turned our attention to the bronchiole that always accompany SPA and compared their diameters (Figure 1 and Figure 2 A and 2B) The purpose of this study was to evaluate the pulmonary vascular morphology of neonates with HLHS and to determine whether a restrictive atrial septal defect is associated with more severe pulmonary vascular changes. We hypothesized that HLHS patients with restrictive ASD have more severely hypoplastic small pulmonary arteries.
|
|
| Materials and Methods |
|---|
|
|
|---|
1.5 m/s in velocity) from the left atrium to the right atrium across the atrial septum at the time of birth. Two cases with intact atrial septum were included in R(+) group. The criterion for inclusion in the nonrestrictive ASD [R() group] was a mean gradient of <8 mm Hg. According to disease type, there were 9 MA/AA cases, 3 MS/AA cases, and 2 MS/AS cases. The clinical profiles and outcomes of the patients are summarized in the Table. The size of the ASD was determined from the maximal width of the color jet flow on the left atrial side of the communication on the subcostal long-axis and short-axis views. Tricuspid regurgitation was assessed by color flow mapping in the apical 4-chamber view with the ratio of color flow jet area to right atrial area used to determine its magnitude (none, grade 0; area ratio <0.2, grade 1; area ratio 0.2 to 0.4, grade 2; and area ratio >0.4, grade 3).9
|
As a control group (C group), we examined tissue from 12 autopsy cases with no congenital heart or pulmonary disease and in which death occurred between 1 and 50 days of age (mean age, 14.0±15.2 days). All control group infants had been born full-term. Five of them had died of infection, 2 as a result of accidents, 3 from brain hemorrhage, 1 from a tumor, and 1 from a metabolic disorder.
Tissue Preparation
One block of tissue from each lung was fixed in 10% formalin, and paraffin histological sections were prepared. To prevent the influence of overextension or underextension of SPA by fluid pressure, the tissue was not injected with any fluid under pressure during fixation.10 Thirty step sections at 50-µm intervals were prepared in each case. Elastica-Goldner staining was performed,11 and the following were assessed: (1) severity of intimal lesions; (2) radius and medial thickness of SPA and small pulmonary veins (SPV), which are pulmonary veins with a muscular coat observed in biopsy specimens; their radius range is
25 µm to 250 µm; (3) radius of bronchioles, and the radius of SPA accompanying the bronchioles (supernumeral arteries12,13 that did not run parallel to the bronchioles were excluded); (4) radial alveolar counts (RAC), which reflects lung maturity; and (5) the presence of lymphangiectasia. Slides of pathology specimens were qualitatively and quantitatively examined by the investigators blinded to the status of the atrial septum.
Measurements
The medial thickness (DA) and radius (RA) of the SPA and SPV were measured by a previously reported morphohistometric method.10 All SPA were scanned with a digitizing camera (Olympus PDMC/II/OL), and the images were fed into a Macintosh computer (PowerMac G4). All morphohistological measurements below were performed using National Institutes of Health image version 1.53 software. Assuming uniform thickness, DA and RA were calculated from the length of the internal elastic membrane (LA) and the area of the media (SA) by means of the equation
(Figure 3A):
|
|
|
|
|
The values of RA and DA were obtained from at least 20 samples from each case and plotted on a logarithmic coordinate system. Linear regressions of RA and DA were performed, and the DA value at R=100 µm (DR=100 µm) was calculated so that medial thickness of SPA and SPV could be compared.
The radius of bronchioles (RB) accompanying preacinar SPA was measured by our previously reported method,8 a modification of the technique of Bernd et al.14 Because bronchioles are sometimes distorted and contracted in prepared specimens, in our study their radius was calculated with the internal basement membrane extended to form a circle to avoid errors resulting from distortion or contraction. The length of the basement membrane of the bronchiole (LB) was measured (Figure 3A), and RB was calculated from the equation:
|
|
The values of RA and RB were obtained in at least 20 pairs of bronchioles and vessels from each tissue specimen and plotted on a logarithmic coordinate system(Figure 3B). Linear regressions of these 2 radii were performed, and the SPA radius when the radius of the accompanying bronchiole was 100 µm was calculated, so that the radii of SPA in relation to the accompanying bronchiole could be compared among cases. Only transversely cut airways and SPA were used for these measurements. To avoid the influence of branching, we excluded pairs in which the arterial and bronchial branching occurred in different planes (in such situations, a single bronchus might be accompanied by 2 arteries).
RAC were made according to the description of Emery and Mithal, with the modifications of Cooney and Thurbeck.15,16 A perpendicular line was drawn from the center of a respiratory bronchiole lined by epithelium in one part of the wall back to the nearest, definite connective tissue septum, and the number of alveoli that the line passed through was counted. The procedure measures the number of airways in the secondary lobule and is suitable for material available in a retrospective study. The mean RAC in each case was calculated from all suitable areas in all available sections. Only uninflated lungs were used for the assessment in our study group.
The severity of the intimal lesions was evaluated by using the Heath-Edwards classification17 and the index of pulmonary vascular disease as described in our previous report.10 The index of pulmonary vascular disease was determined by classifying the pulmonary vascular intimal lesions of the SPA into 4 grades, with a rating of 1 to 4 assigned to each artery, and the mean rating was calculated for each case. The ratings were based on the following pathologic findings: 1, no intimal lesions; 2, cellular proliferation of the intima; 3, fibrous thickening of the intima; and 4, destruction of the media.
We also examined all of the slides we had prepared for the presence or absence of lymphangiectasia. Lymphangiectasia is a condition in which lymph vessels are excessively dilated, giving rise to clusters of grossly distended lymph vessels in tissue.18 If markedly dilated lymphatics having a thin endothelial cell lining were observed within most of the interlobular septa and beneath the visceral pleural surface, then lymphangiectasia was concluded to be present.
All these measurements were made and confirmed by observers blinded to the classification of the patients into restrictive, nonrestrictive, and control cases.
Statistics
All values are reported as means±SD. Because the standard value calculated from the 24 control cases varied with age, statistical comparisons among groups were made by analysis of covariance using age as a covariant factor. P<0.05 was considered significant. All statistical analyses were performed using Statview version 5.0 software.
| Results |
|---|
|
|
|---|
The causes of death in the R(+) group were extensive hypoxia resulting in preoperative death in 2 cases (balloon atrial septostomy [BAS] had been performed in 1 of them, but no intervention had been performed in the other), severe hypoxia despite reconstruction of BTS or RV-PA conduit in 5 cases, and severe bleeding causing hemodynamic instability in 1 case. Transthoracic or transesophageal or direct echocardiography was performed in every case in the R(+) group and the absence of obstruction of the shunt because of technical problems and incomplete ASD enlargement was confirmed. The causes of death in the R() group, however, were low-output syndrome secondary to heart failure in 2 cases, severe hypoxia and hemodynamic instability in 1 case, multiple organ failure in 1 case, sepsis in 1 case, and performance of a biopsy at the time of the Norwood operation in 1 case. Based on the Sat O2 values, there were no cases of persistent pulmonary high flow.
When histomorphometric parameters were calculated by linear regressions (DR=100 µm and SPA radius at an accompanying a bronchiole with a radius of 100 µm), P<0.05 in all cases.
Radius of SPA Accompanying a Bronchiole Having a Radius of 100 µm
The radius of the SPA was 34.0±10.8 µm in the R(+) group and 46.6±8.5 µm in the R() group, and the values in both groups were significantly smaller than in the C group (70.5±8.4 µm, both P<0.0001). The difference between the R(+) group and R() group was also significant (P=0.0022; Figure 4). The smallest radius was 22.5 µm in a patient with an intact atrial septum without any clear decompression pathway who died at 2 days of age from severe hypoxia and severe pulmonary hypertension that failed to respond to therapy. According to our previous study,8 the radius of the SPA of normal infants is
65 µm at birth, increases during the first 2 months, and then remains stable at
80 µm from 2 to 10 months. All the radii in the HLHS patients in the present study were less than the 5% to 95% confidence limits, and the largest radius was 58.7 µm in a 40-day-old girl in the R() group.
|
RAC
The RAC was 3.7±0.9 in the control group. The RAC in the R(+) group and the R() group were 3.6±0.9 µm and 3.4±0.6 µm, respectively, and not significantly different from the value in the C group (P=0.35 and P=0.31, respectively). The difference between the 2 HLHS groups was not significant. The RAC in all HLHS cases was within the 5% to 95% confidence limits of the control group (Figure 5).
|
Intimal Lesions
All index of pulmonary vascular disease values for the intimal lesions in the HLHS cases were 1.0, and Heath-Edwards classification was grade 1. Because all of the subjects were infants younger than 40 days of age, intimal lesions seemed to not have yet developed.
Lymphangiectasia
No lymphangiectasia was detected in the C group, but it was present in 6 (75%) of 8 cases in the R(+) group and in 3 (50%) of the 6 cases in the R() group [group C versus R(+) group, P<0.01; group C versus R() group, P<0.01; R(+) group versus R() group, P=0.19, NS]. Interstitial emphysema was observed in all of the cases in which lymphangiectasia was present.
Medial Thickness of SPA
The medial thickness of the SPA in the C group ranged from 5.6 to 13.1 µm (7.6±2.3 µm). The medial hypertrophy regressed during the first month after birth and remained almost stable at
6 to 8 µm. By contrast, the medial thickness of the SPA in the HLHS cases was significantly greater than in the controls (15±3.5 µm and 12±2.8 µm, P<0.0001 and P=0.021, respectively). The SPA in the R(+) group tended to be thicker than in the R() group, but the difference was not statistically significant (P=0.075; Figure 6A). However, the number of cases was limited, and if there had been a large number, then the difference may have been significant.
|
Medial Thickness of SPV
The medial thickness of the SPV in the C group was 0.7 to 3.7 µm (1.7±0.90 µm) and remained constant at
2 to 3 µm after birth. The medial thickness of the SPV in the HLHS cases was significantly greater than in the C group [R(+) group, 6.5±2.6 µm, P<0.0001; R() group, 4.1±1.6 µm, P=0.011]. There was a slight difference between the R(+) group and the R() group (P=0.019; Figure 6B).
| Discussion |
|---|
|
|
|---|
Our results showed much smaller SPA compared with the accompanying bronchioles in the HLHS with restrictive ASD cases. In the C group, the radius of the SPA accompanying bronchioles having a radius of 100 µm was
65 µm at birth and gradually increased to 80 µm by 2 months of age,8 whereas the smallest diameter in the HLHS with restrictive ASD cases was 22.5 µm. Although the SPA in HLHS without restrictive ASD were also smaller than in the controls, the difference in SPA size in HLHS with restrictive ASD and HLHS without restrictive ASD was statistically significant. No reports had ever clearly described hypoplasia or underdevelopment of the pulmonary artery in HLHS patients, and one reason for this is that there had been no quantitative method of clearly identifying the hypoplasia of small pulmonary arteries. Several published reports have discussed the problem of underdevelopment of the pulmonary vasculature or reduction in the number of lung vessels, but SPA counts have been questioned, because other studies had shown the number of SPA was either not decreased or even increased.22,23 Mooi and Wagenvoort have stated that the controversy regarding the underdevelopment or disappearance of pulmonary vessels to a large extent centers on methodology.24 To avoid the drawbacks of previous methods, we devised a novel method of measuring the degree of hypoplasia in small pulmonary arteries in histological sections and used it in our study of TAPVC patients.8
It seems reasonable to assume that underdevelopment of the SPA results in increased pulmonary vascular resistance and limits pulmonary blood flow. If the limitation of the pulmonary blood flow is appropriate, it benefits patients with functional hypoplastic left heart syndrome by limiting excessive flow. A critically restrictive ASD, however, will cause increasing hypoxemia and death.3 Pulmonary vascular maldevelopment has significant implications in HLHS, because the current palliative interventions require low pulmonary resistance to ensure adequate pulmonary blood flow via aortopulmonary or right ventricular pulmonary artery shunts (ie, Norwood procedure), and, ultimately, a cavopulmonary connection. Heart transplantation also remains a potential treatment modality,25 but the outcome has not been satisfactory, and its success is optimized by normal pulmonary vasculature, which prevents post-transplantation right ventricular failure. The results of our analysis of the pathology imply that pulmonary vascular abnormalities that pose a significant physiological risk to later cavopulmonary connections or transplantation are present in essentially all patients with HLHS and a restrictive ASD. Day et al26 histologically studied the pulmonary vessels in biopsy specimens from 20 newborns (mainly HLHS cases) awaiting heart transplantation by nitrogen therapy. They found potentially irreversible pulmonary vascular disease in 1 HLHS case with restrictive ASD after performing BAS. This seems to suggest that HLHS with restrictive ASD is complicated by early development of pulmonary vascular lesions, and their development may be related to the hypoplasia of SPA.
The pathogenesis of the reduced size of the SPA is not understood. Some studies have shown that banding a pulmonary artery in newborn sheep leads to the development of fewer and smaller intra-acinar arteries than normal,27 and the SPA of patients with pulmonary atresia are said to be fewer than normal.28 Our previous study also demonstrated hypoplasia in TAPVC with preoperative pulmonary venous obstruction, implying that the hypoplasia of the SPA may be related to restrictive pulmonary venous return in the fetal period.8 Although blood flow via the pulmonary circulation has been described to be minimal, accounting for 3% to 7% of the total right ventricular output,29 it represents flow that returns to the left atrium. In patients with mitral atresia or severe mitral stenosis, decompression of this return of flow to the left atrium must occur via the foramen ovale. The absence of an adequate-size foramen ovale is likely to result in left atrial hypertension in utero that is transmitted to the pulmonary venous structures, producing secondary pulmonary venous hypertension, and may reduce pulmonary arterial flow. Few articles have described the pulmonary flow in patients with HLHS with restrictive ASD (IAS). Figure 7 is a Doppler ultrasonogram of a patient with HLHS with IAS at term. It showed that the flow velocity in the main right pulmonary artery was decreased, despite normal flow velocity in the pulmonary trunk. Although further study is needed, the flows in these patients are decreased, and normal growth of pulmonary vascular bed is prevented.
|
With regard to other histomorphometric parameters, the RAC is said to reflect the degree of alveolar hypoplasia or alveolar surface complexity, which is a significant component in hypoplasia of the lung and parallels lung maturity.15,16 George et al reported 10 cases of congenital diaphragmatic hernia in infants who died in the immediate perinatal period, and the RAC was reduced in every case, possibly because of persistent lung compression during the fetal period.30,31 In our study, however, the RAC was not significantly reduced in the HLHS cases, and all values were within the 5% to 95% confidence limits of the control curve. The mechanism of the vascular hypoplasia in HLHS is different from the mechanism of the alveolar immaturity. Lymphangiectasia was previously claimed to be the main cause of the poor outcome of HLHS with restrictive ASD cases, but there was no significant difference between the HLHS cases with restrictive ASD and the HLHS cases without restrictive ASD, suggesting that lymphangiectasia may be not necessarily related to restrictive ASD.
It remains unknown how long it takes for the hypoplastic small pulmonary arteries to grow sufficiently. Moreover, because of the lack of available material, our knowledge is almost completely limited to autopsy cases, and the limitations imposed by hypoplasia of SPA on survival after the Norwood operation are unclear. According to our previous study, the SPA of normal infants grow gradually over several months. If patients with hypoplastic SPA receive appropriate (not excessive) pulmonary flow, then the SPA should grow gradually without developing plexogenic arteriopathy, and the second or third stage Fontan-type operation can be performed successfully.
There were several limitations to this study. It was a retrospective study, and the number of cases was limited. The series of patients does not represent a random sample of HLHS patients during the study period. In addition, because biopsy cannot be approved for ethical reasons, all of the lungs we studied were taken from autopsy cases after operations except in 1 case. Although the patients were examined by echocardiography for possible technical failures, there is a possibility that inappropriate surgical repair (ie, excessive or insufficient pulmonary blood flow, inadequate surgical septectomy) had an influence on postnatal changes in SPA and SPV. However, our results suggest that SPA hypoplasia is present in cases of HLHS with restrictive ASD. This, combined with the finding by others that restrictive ASD is a negative factor for survival, leads us to speculate that restrictive ASD is related to the poor outcome of these patients, although further study is needed to support our findings.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2. Helton JG, Aglira BA, Chin AJ, et al. Analysis of potential anatomic or physiologic determinants of outcome of palliative surgery for hypoplastic left heart syndrome. Circulation. 1986; 74 (suppl 1): I70I76.
3. Boucek MM, mathis CM, Kanakriyeh MS et al. Management of the critically restrictive atrial septal defect awaiting infants cardiac transplantation. Am J Cardiol. 1992; 70: 559(abstract).
4. Canter C, Moorehead S, Huddleston CB, et al. restrictive atrial septal communication as a determinant outcome of cardiac transplantation for hypoplastic left heart syndrome. Circulation. 1993; 88 (suppl 2): II456II460.
5. Graziano JN, Heidelberger KP, Ensing GJ, et al. The Influence of a Restrictive Atrial Septal Defect on Pulmonary Vascular Morphology in Patients with Hypoplastic Left Heart Syndrome. Pediatr Cardiol. 2002; 23: 146151.[CrossRef][Medline] [Order article via Infotrieve]
6. Luciani GB, Pessotto R, Mombello A, et al. Hypoplastic Left Heart Syndrome with Restrictive Atrial Septal Defect and Congenital Pulmonary Lymphangiectasis. Cardiovasc Pathol. 1999; 8: 4951.[CrossRef][Medline] [Order article via Infotrieve]
7. Rychik J, Rome JJ, Collins MH, et al. The hypoplastic left heart syndrome with intact atrial septum: atrial morphology, pulmonary vascular histopathology and outcome. J Am Coll Cardiol. 1999; 34: 554560.
8. Maeda K, Yamaki S, Yokota M, et al. Hypoplasia of the small pulmonary arteries in Total anomalous pulmonary venous connection with obstructed pulmonary venous drainage. J Thorac Cardiovasc Surg. 2004; 127: 448456.
9. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 1987; 75: 175183.
10. Goldner J. A modification of the Masson trichrome technique for the routine laboratory purpose. Am J Pathol. 1938; 14: 237243.
11. Elliot FM, Reid L. Some new facts about the pulmonary artery and its branching pattern. Clin Radiol. 1965; 16: 193198.[CrossRef][Medline] [Order article via Infotrieve]
12. Hislop A, Reid L. Pulmonary arterial development during childhood: branching pattern and structure. Thorax. 1973; 28: 129135.
13. Yamaki S, Tezuka F. Quantitative analysis of pulmonary vascular disease in complete transposition of the great arteries. Circulation. 1976; 54: 805809.
14. Berend N, Woolcock AJ, Marlin GE. Relationship between bronchial and arterial diameters in normal human lungs. Thorax. 1979; 34: 354358.
15. Emery JL, Mithal A. The number of alveoli in the terminal respiratory unit of man during late intrauterine life and childhood. Arch Dis Child. 1960; 35: 544547.
16. Cooney TP, Thurlbeck WM. The radial alveolar count method of Emery and Mithal: a reappraisal of postnatal lung growth. Thorax. 37: 572579.
17. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation. 1958; 18: 533547.[Medline] [Order article via Infotrieve]
18. Yamaki S, Tsunemoto M, Shimada M, et al. Quantitative analysis of pulmonary vascular disease in total anomalous pulmonary venous connection in sixty infants. J Thorac Cardiovasc Surg. 1992; 104: 728735.[Abstract]
19. Grant CA, Robertso B. Microangiography of the pulmonary arterial system in hypoplastic left heart syndrome. Circulation. 1972; 45: 382388.
20. Haworth SG, Reid L. Quantitative structural study of pulmonary circulation in the newborn with aortic atresia, stenosis, or coarctation. Thorax. 1977; 32: 121128.
21. Neumann MP, Heidelberger KP, Dick M, et al. Pulmonary vascular changes associated with hypoplastic left heart syndrome. Pediatr Cardiol. 1980; 1: 301306.[CrossRef]
22. Haworth SG, Radley-Smith R, Yacoub M. Lung biopsy findings in transposition of the great arteries with ventricular septal defects: potentially reversible pulmonary vascular disease is not synonym with operability. J Am Coll Cardiol. 1987; 9: 327333.[Abstract]
23. Takahashi T, Wagenvoort CA. Density of muscularized arteries in the lung. Its role in congenital heart disease and its clinical significance. Arch Patho Lab Med. 1983; 107: 2328.
24. Mooi WJ, Wagenvoort CA. Decreased number of pulmonary blood vessels: reality or artifact? J Pathol. 1983; 141: 441447.[CrossRef][Medline] [Order article via Infotrieve]
25. Chiavarelli M, Gundry SR, Razzouk AJ, et al. Cardiac transplantation for infants with hypoplastic left heart syndrome. J Am Med Asoc. 270: 29442947.
26. Day RW, Barton AJ, Pysher TJ, et al. Pulmonary vascular resistance of children treated with nitrogen during early infancy. Ann Thorac Surg. 1998; 65: 14001404.
27. Wallen LD, Perry SF, Alston JT, et al. Morphometric study of the role of pulmonary arterial flow in fetal lung growth in sheep. Pediatr Res. 1990; 27: 122127.[Medline] [Order article via Infotrieve]
28. Haworth SG, Reid L. Quantitative structural study of pulmonary circulation in the newborn with pulmonary atresia. Thorax. 1977; 32: 129133.
29. Heyman MA. Fetal and postnatal circulations: pulmonary circulation. In: Emmanouilides GC, Riemenschneider TA, Allen HD, eds. Gutgesell Moss and Adams Heart Disease in Infants, Children, and Adolescents, 5th ed. Baltimore: Williams & Wilkins; 1995: 4147.
30. Geggel RL, Murphy JD, Langeleben D, et al. Congenital diaphragmatic hernia: arterial structural change in persistent pulmonary hypertension after surgical repair. J Pediatr. 1985; 107: 457464.[CrossRef][Medline] [Order article via Infotrieve]
31. George DK, Cooney TP, Chiu BK, et al. Hypoplasia and immaturity of the terminal lung unit (acinus) in congenital diaphragmatic hernia. Am Rev Respir Dis. 1987; 136: 947950.[Medline] [Order article via Infotrieve]
32. Van Der Mooren K, Barendregt LG, Wladimiroff JW. Flow velocity wave forms in the human fetal ductus artriosus during the normal second half of pregnancy. Pediatr Res. 1991; 30: 387490.
33. Rasenen J, Huhta JC, Weiner S et al. Fetal branch pulmonary arterial vascular impedance during the second half of pregnancy. Am J Obstet Gynecol. 1996; 174: 14411449.[CrossRef][Medline] [Order article via Infotrieve]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |